Pharmac has missed a golden opportunity to allow more Kiwis access to a new breast cancer drug, a move that would have brought New Zealand into line with the rest of the world and removed a disparity that hits Māori and Pasifika hardest, says Breast Cancer Foundation NZ
Te Pātaka Whaioranga – Pharmac is transitioning to a trastuzumab biosimilar, Herzuma, from the currently funded brand, Herceptin, as a result of a competitive procurement process. The treatment is currently funded for people with metastatic HER2 positive breast cancer
The RNZCGP has accused the National Party of “political gamesmanship” over its plan to slash the number of people receiving free prescriptions to fund new cancer drugs
Te Pātaka Whaioranga – Pharmac is interested to hear from pharmaceutical suppliers who manufacture vaccines that protect against COVID-19 and offer the opportunity to submit funding applications for future consideration
Te Pātaka Whaioranga – Pharmac is proposing to widen access to temozolomide, an oral anti-cancer treatment, for people with a type of brain cancer called glioma
Te Pātaka Whaioranga – Pharmac has published the record of the March Rare Disorders Advisory Committee meeting, sharing details on a number of funding applications including those for spinal muscular atrophy (SMA)
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management